Alphabetical listing of all products

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Prices
  • 5 mg - 85 EUR
  • 25 mg - 340 EUR
  • 100 mg - 1020 EUR

Afatinib

Afatinib is a tyrosine kinase inhibitor that irreversibly inhibits the activity of human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) kinases. It is a candidate drug against non-small cell lung carcinoma, glioma, and cancers of the breast, prostate, head and neck.

catalogue number: A010
synonyms: BIBW2992
CAS: 850140-72-6
MW: 485.94 g/mol

References
Strahlenther Onkol. 2007 May;183(5):256-64. PMID: 17497097
Oncogene. 2008 Aug 7;27(34):4702-11. PMID: 18408761
Br J Cancer. 2011 Nov 8;105(10):1554-62. PMID: 21970876